RxDoctor Payments Data

Amanda Whistler

Family · Festus, MONPI 1497220594

Payments from drug & device makers

$1,387in general payments, 2019–2025

Across 89 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$200
  • Lilly USA, LLC$175
  • AbbVie$151
  • AstraZeneca$145
  • Biohaven Pharmaceuticals, Inc.$144
  • Novartis$128
  • plus $443 from 12 others

What the payments were for

  • Food & beverage$1,387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,387 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$13,627
Medicare patients
49
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Festus

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →